GAMMORA by Code Pharma

Code Pharma is the developer of the promising potential cure Gammora for HIV. Gammora is a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, originally discovered at the Hebrew University in Israel.

Code Pharma's team investigate the peptide in in-vitro studies, animals models and clinical studies to ensure the safety and efficacy of the peptide. In parallel, drug development studies and investigations were made to deliver the drug with patient compliance.